Showing results (41-50 of 289) with videos related to
Sort By:
Pageof 29
The Journal of Experimental Medicine|June 1, 1989
Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion moleculeL L Lanier, R Testi, J Bindl, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1997
CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cellsK Söderström, B Corliss, L L Lanier, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2)H Arase, T Saito, J H Phillips, et al.The Journal of Experimental Medicine|December 1, 1993
Human natural killer cell committed thymocytes and their relation to the T cell lineageM J Sánchez, H Spits, L L Lanier, et al.Science (New York, N.Y.)|April 21, 1995
Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytesJ H Phillips, J E Gumperz, P Parham, et al.Human Immunology|February 5, 2000
NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signalsA B Bakker, J Wu, J H Phillips, et al.Molecular Immunology|February 13, 2001
2B4-mediated activation of human natural killer cellsS G Tangye, H Cherwinski, L L Lanier, et al.The Journal of Experimental Medicine|July 1, 1988
The effects of recombinant interleukin 2-activated natural killer cells on autologous peripheral blood hematopoietic progenitorsA Nagler, P L Greenberg, L L Lanier, et al.The Journal of Experimental Medicine|December 1, 1996
Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cellsN M Valiante, J H Phillips, L L Lanier, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndromeS G Tangye, J H Phillips, L L Lanier, et al.Pageof 29